CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $36.2K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 6
- 13F valueReported value at the end of Q2 2026
- $36.2K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CYDY, Q2 2026
No superinvestor reported holding CYDY at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by CytoDyn Inc. insiders from Form 4, newest first.
No open-market purchases or sales by CytoDyn Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in CytoDyn Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Diversified Trust Co | 45,790 | $10.9K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 45,001 | $10.7K | 0.00% | 00.0% | Unchanged |
| Next Capital Management LLC | 25,000 | $5.97K | 0.00% | 00.0% | Unchanged |
| Horizon Financial Services, LLC | 18,200 | $4.35K | 0.00% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 9,488 | $2.27K | 0.00% | 00.0% | Unchanged |
| Caz Investments LP | 8,000 | $1.91K | 0.00% | +4,000+100.0% | Added |